FDA Podcast: The Dangers Associated with Propoxyphene


A pharmacist with the FDA explains the reasoning behind the concerns with propoxyphene.

Mary Kremzner, a pharmacist in the Division of Drug Information with the FDA, discusses the recent recommendation made by the FDA to medical professionals to stop administering propoxyphene.

Click here to access this third-party resource.

Related Videos
Peter Lio, MD: Minimizing Painful Pediatric Dermatologic Procedures
Educating Third-Year Students on Opioid Use Disorder, Pain Management
© 2024 MJH Life Sciences

All rights reserved.